These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 12775615)

  • 1. Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.
    Melander H; Ahlqvist-Rastad J; Meijer G; Beermann B
    BMJ; 2003 May; 326(7400):1171-3. PubMed ID: 12775615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Publication bias in systematic reviews.
    Barbui C; Cipriani A
    Arch Gen Psychiatry; 2007 Jul; 64(7):868. PubMed ID: 17606823
    [No Abstract]   [Full Text] [Related]  

  • 3. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
    Eyding D; Lelgemann M; Grouven U; Härter M; Kromp M; Kaiser T; Kerekes MF; Gerken M; Wieseler B
    BMJ; 2010 Oct; 341():c4737. PubMed ID: 20940209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
    Lexchin J; Bero LA; Djulbegovic B; Clark O
    BMJ; 2003 May; 326(7400):1167-70. PubMed ID: 12775614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals.
    van Lent M; Overbeke J; Out HJ
    PLoS One; 2014; 9(8):e104846. PubMed ID: 25118182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
    Whittington CJ; Kendall T; Fonagy P; Cottrell D; Cotgrove A; Boddington E
    Lancet; 2004 Apr; 363(9418):1341-5. PubMed ID: 15110490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-lag bias in trials of pediatric antidepressants: a systematic review and meta-analysis.
    Reyes MM; Panza KE; Martin A; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):63-72. PubMed ID: 21156271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials.
    de Vries YA; Roest AM; Turner EH; de Jonge P
    Psychol Med; 2019 Sep; 49(12):2020-2026. PubMed ID: 30261934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
    Hansen RA; Gartlehner G; Lohr KN; Gaynes BN; Carey TS
    Ann Intern Med; 2005 Sep; 143(6):415-26. PubMed ID: 16172440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants and children. Buried data can be hazardous to a company's health.
    Marshall E
    Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressing research.
    Lancet; 2004 Apr; 363(9418):1335. PubMed ID: 15110484
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
    Rasmussen N; Lee K; Bero L
    Trials; 2009 Dec; 10():116. PubMed ID: 20015404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant treatment for postnatal depression.
    Molyneaux E; Howard LM; McGeown HR; Karia AM; Trevillion K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002018. PubMed ID: 25211400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.